Cytokinetics Inc (CYTK)

EBITDA

-$195.13M

Quarterly · Period ending: · USD

CYTK logo

CYTK EBITDA

Latest reported-$195.13M
CYTK Quarterly EBITDA (-$5.01M → -$195.13M)
High-resolution chart · PNG

CYTK ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytokinetics Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-195,131,000
-169,318,000
-180,170,000
-277,177,000
-107,820,000
-136,130,000
-125,043,000
-135,836,000
-116,613,000
-115,991,000
-113,497,000
-113,572,000
-113,415,000
-115,265,000
-119,453,000
-124,455,000
-8,603,000
-78,794,000
-21,347,000
-68,508,000
-54,067,000
-39,784,000
-33,790,000
5,720,000
-30,560,000
-29,954,000
-21,985,000
-22,571,000
-25,392,000
-23,091,000
-20,559,000
-16,323,000
-21,669,000
-24,616,000
-35,163,000
-27,195,000
-24,143,000
-22,394,000
3,412,000
34,142,000
-10,841,000
-11,784,000
-8,870,000
-8,742,000
-10,442,000
-8,764,000
8,558,000
-5,872,000
-8,285,000
-8,665,000
6,520,000
-12,510,000
-14,948,000
-12,523,000
-11,360,000
-9,935,000
-8,825,000
-9,747,000
-11,579,000
-10,377,000
-13,228,000
-11,274,000
-11,130,000
-12,033,000
-12,606,000
-11,631,000
-12,875,000
-7,595,000
59,753,000
-10,070,000
-10,596,000
-13,601,000
-15,402,000
-14,551,000
-14,299,000
-12,530,000
-13,819,000
-13,009,000
-16,274,000
-15,275,000
-14,145,000
-12,717,000
-10,953,000
-9,969,000
-10,330,000
-10,320,000
-11,475,000
-9,829,000
-8,706,000
-5,149,000
-40,523,000
2,644,000
-4,732,000
-5,007,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.